For: | Weingarden AR, Gubatan J, Singh S, Balabanis TC, Patel A, Sharma A, Habtezion A. Immune checkpoint inhibitor-mediated colitis is associated with cancer overall survival. World J Gastroenterol 2022; 28(39): 5750-5763 [PMID: 36338892 DOI: 10.3748/wjg.v28.i39.5750] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i39/5750.htm |
Number | Citing Articles |
1 |
Masaya Iwamuro, Sakiko Hiraoka, Motoyuki Otsuka. A case of immune checkpoint inhibitor-associated colitis treated with infliximab. Okayama Igakkai Zasshi (Journal of Okayama Medical Association) 2024; 136(2): 69 doi: 10.4044/joma.136.69
|
2 |
Kristian C. Williams, Abigail Gault, Amy E. Anderson, Christopher J. Stewart, Christopher A. Lamb, R. Ally Speight, Neil Rajan, Ruth Plummer, Arthur G. Pratt. Immune-related adverse events in checkpoint blockade: Observations from human tissue and therapeutic considerations. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1122430
|